John Ehrlich

1.9k total citations
21 papers, 353 citations indexed

About

John Ehrlich is a scholar working on Pharmacology, Molecular Biology and Cell Biology. According to data from OpenAlex, John Ehrlich has authored 21 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in John Ehrlich's work include Microbial Natural Products and Biosynthesis (8 papers), Plant Disease Resistance and Genetics (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). John Ehrlich is often cited by papers focused on Microbial Natural Products and Biosynthesis (8 papers), Plant Disease Resistance and Genetics (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). John Ehrlich collaborates with scholars based in United States. John Ehrlich's co-authors include Bernard J. Sloan, Quentin R. Bartz, Wilton A. Rightsel, Glen J. Dixon, Paul R. Burkholder, James C. French, H. J. Koepsell, Peter Thompson, M. W. Fisher and David Gottlieb and has published in prestigious journals such as Nature, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

John Ehrlich

20 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Ehrlich United States 10 154 103 65 58 43 21 353
J. P. Rosselet United States 9 155 1.0× 123 1.2× 17 0.3× 46 0.8× 45 1.0× 12 398
M. Hoehn United States 9 130 0.8× 181 1.8× 35 0.5× 95 1.6× 25 0.6× 11 322
George M. Luedemann United States 10 275 1.8× 274 2.7× 70 1.1× 82 1.4× 36 0.8× 16 603
J. R. Turner United States 14 269 1.7× 195 1.9× 57 0.9× 101 1.7× 43 1.0× 22 459
A. P. Maclennan United States 13 227 1.5× 32 0.3× 51 0.8× 139 2.4× 115 2.7× 14 517
J. J. Black 7 138 0.9× 104 1.0× 24 0.4× 28 0.5× 15 0.3× 8 330
RYOZO UTAHARA Japan 12 371 2.4× 228 2.2× 47 0.7× 160 2.8× 43 1.0× 26 644
B. Carss Canada 8 157 1.0× 39 0.4× 22 0.3× 75 1.3× 22 0.5× 9 326
H. Pagani 13 303 2.0× 266 2.6× 86 1.3× 131 2.3× 33 0.8× 16 556
A. Rosselet Switzerland 7 215 1.4× 131 1.3× 34 0.5× 71 1.2× 40 0.9× 17 485

Countries citing papers authored by John Ehrlich

Since Specialization
Citations

This map shows the geographic impact of John Ehrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ehrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ehrlich more than expected).

Fields of papers citing papers by John Ehrlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ehrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ehrlich. The network helps show where John Ehrlich may publish in the future.

Co-authorship network of co-authors of John Ehrlich

This figure shows the co-authorship network connecting the top 25 collaborators of John Ehrlich. A scholar is included among the top collaborators of John Ehrlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ehrlich. John Ehrlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ehrlich, John, et al.. (2000). Actinobolin, a new broad-spectrum antibiotic; origin and biological evaluation.. PubMed. 6. 497–504.
2.
Ehrlich, John, et al.. (1977). The bacteriolytic effect of human dentoalveolar purulent exudates and leukocyte extracts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(4). 39–44. 4 indexed citations
3.
Ehrlich, John, et al.. (1972). Butirosin, a New Aminoglycosidic Antibiotic Complex: Bacterial Origin and Some Microbiological Studies. Antimicrobial Agents and Chemotherapy. 2(2). 79–83. 37 indexed citations
4.
Ehrlich, John, et al.. (1965). SEARCHING FOR ANTIVIRAL MATERIALS FROM MICROBIAL FERMENTATIONS. Annals of the New York Academy of Sciences. 130(1). 5–16. 29 indexed citations
5.
Rightsel, Wilton A., et al.. (1964). Antiviral Activity of Gliotoxin and Gliotoxin Acetate. Nature. 204(4965). 1333–1334. 61 indexed citations
6.
Rightsel, Wilton A., Bernard J. Sloan, John Ehrlich, et al.. (1963). Antiviral Activity of Tenuazonic Acid. Nature. 200(4913). 1338–1339. 60 indexed citations
7.
Douros, John, et al.. (1963). CHALCOMYCIN, A NEW ANTIBIOTIC: BIOLOGICAL STUDIES. Canadian Journal of Microbiology. 9(5). 665–669. 3 indexed citations
8.
Ehrlich, John, et al.. (1960). Biological studies of streptimidone, a new antibiotic.. PubMed. 10. 9–16. 9 indexed citations
9.
Fisher, M. W., et al.. (1959). Biological studies of paromomycin.. PubMed. 9. 730–8. 21 indexed citations
10.
Ehrlich, John, et al.. (1956). Strains of Streptomyces, the sources of azaserine, elaiomycin, griseoviridin, and viridogrisein.. PubMed. 6(2). 100–15. 16 indexed citations
11.
Burkholder, Paul R., et al.. (1955). The Identity of Viomycin-Producing Cultures of Streptomyces. Bulletin of the Torrey Botanical Club. 82(2). 108–108. 9 indexed citations
12.
Ehrlich, John, William H. Feldman, M. W. Fisher, et al.. (1954). Elaiomycin, a new tuberculostatic antibiotic; biologic studies.. PubMed. 4(3). 338–42. 6 indexed citations
13.
Burkholder, Paul R., et al.. (1954). CRITERIA OF SPECIATION IN THE GENUS STREPTOMYCES. Annals of the New York Academy of Sciences. 60(1). 102–123. 27 indexed citations
14.
Ehrlich, John, et al.. (1954). Azaserine, A New Tumour-Inhibitory Substance: Antibiotic Studies of Azaserine. Nature. 173(4393). 72–72. 33 indexed citations
15.
Ehrlich, John, et al.. (1954). Azaserine: microbiological studies.. PubMed. 4(7). 775–91. 8 indexed citations
16.
Ehrlich, John, et al.. (1953). Streptomyces venezuelae: further soil studies.. PubMed. 3(11). 1141–8. 5 indexed citations
17.
Ehrlich, John, et al.. (1952). Streptomyces venezuelae: soil studies.. PubMed. 2(11). 595–6. 4 indexed citations
18.
Ehrlich, John, et al.. (1951). Agar diffusion methods for the assay of viomycin.. PubMed. 1(4). 211–6. 7 indexed citations
19.
Ehrlich, John, et al.. (1951). Antimicrobial activity of Streptomyces floridae and of Viomycin.. PubMed. 63(1). 7–16. 11 indexed citations
20.
Ehrlich, John, et al.. (1951). Viomycin productivity of some undefined media.. PubMed. 1(3). 203–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. P. Rosselet Breakdown of academic impact, for papers by M. Hoehn Breakdown of academic impact, for papers by George M. Luedemann Breakdown of academic impact, for papers by J. R. Turner Breakdown of academic impact, for papers by A. P. Maclennan Breakdown of academic impact, for papers by J. J. Black Breakdown of academic impact, for papers by RYOZO UTAHARA Breakdown of academic impact, for papers by B. Carss Breakdown of academic impact, for papers by H. Pagani Breakdown of academic impact, for papers by A. Rosselet
Rankless by CCL
2026